Adolescents' Disease Empowerment and Persistency Technology for Asthma

青少年哮喘疾病赋权和持续技术

基本信息

  • 批准号:
    8520378
  • 负责人:
  • 金额:
    $ 13.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The applicant is an Allergist/lmmunologist who seeks to develop a career as an independent investigator of behavioral interventions that promote the health of urban African American adolescents with persistent asthma. The proposed intervention focuses on peer support, coping peer group problem-solving sessions to record messages about barriers to taking controller medications for asthma and ways to overcome these barriers, and the delivery of these messages developed by study participants themselves to each other throughout the week between music tracks on an MPS player known as the Media Hub. The messages are delivered via the Adolescents' Disease Empowerment and Persistency Technology (ADEPT) for asthma Network Control System to the Media Hub. The career development plan provides further education, training, and mentorship needed to conduct behavioral controlled trials of culturally sensitive, technologybased interventions to promote sustained change. The research plan benefits from prior pilot work, proposes a conceptual model for increasing adherence, and then tests each step in this model. The primary mentor for this award. Dr. Lynda H. Powell, is an expert in behavioral trial methodology and will ensure the applicant applies appropriate theory and methodology to test her conceptual model. The Co-Mentor and Advisors will provide additional guidance in the specific areas of qualitative research, behavioral and social principles of behavior change, and adherence. The research plan aims to: identify ways to improve the ability of ADEPT and other newly proposed technology based platforms to increase adherence; conduct a "proof of concept" pilot study of the newly refined intervention; and conduct a behavioral controlled trial testing the efficacy of ADEPT to improve adherence. At the end of this award, the applicant will be uniquely positioned to submit an ROl grant application to conduct a large-scale behavioral randomized trial evaluating the effectiveness of the ADEPT intervention to improve important health outcomes in urban African American adolescents with asthma. RELEVANCE (See instructions): Alarming rates of emergency room visits and hospitalizations for asthma in inner-city African American adolescents require urgent intervention. The ultimate goal of this research is to reduce the morbidity and mortality of asthma in this population through the use of peer support, enhanced by a culturally sensitive, technology-based MP3 player platform aimed at increasing adherence to daily controller medications. (End of Abstract)
描述(由申请人提供):申请人是一名变态反应学家/免疫学家,他寻求发展作为行为干预的独立调查员的职业生涯,以促进患有持续性哮喘的城市非洲裔美国青少年的健康。拟议的干预措施侧重于同伴支持,应对同伴群体解决问题的会议,以记录有关服用哮喘控制药物的障碍和克服这些障碍的方法的信息,以及研究参与者自己开发的这些信息在一周内在MPS播放器上的音乐曲目之间相互传递。这些信息通过青少年疾病授权和持久性技术(ADEPT)哮喘网络控制系统传递到媒体中心。职业发展计划提供进一步的教育,培训和指导需要进行文化敏感的,基于技术的干预措施,以促进持续变化的行为对照试验。该研究计划受益于先前的试点工作,提出了一个概念模型,以提高依从性,然后测试这个模型中的每一步。他是这个奖项的主要导师。Lynda H.博士鲍威尔是行为试验方法的专家,将确保申请人应用适当的理论和方法来测试她的概念模型。共同导师和顾问将在定性研究、行为改变的行为和社会原则以及坚持的具体领域提供额外的指导。研究计划旨在:确定提高ADEPT和其他新提出的基于技术的平台的能力的方法,以增加依从性;对新改进的干预措施进行“概念验证”试点研究;并进行行为对照试验,测试ADEPT提高依从性的功效。在该奖项结束时,申请人将独特地提交ROI资助申请,以进行大规模行为随机试验,评估ADEPT干预措施对改善城市非洲裔美国哮喘青少年重要健康结果的有效性。相关性(参见说明):市中心非洲裔美国青少年因哮喘急诊和住院的惊人比率需要紧急干预。本研究的最终目标是通过使用同伴支持,通过文化敏感的,基于技术的MP3播放器平台,旨在增加对日常控制药物的依从性,降低该人群中哮喘的发病率和死亡率。 (End摘要)

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Application of Human Augmentics: A Persuasive Asthma Inhaler.
人体增强学的应用:有说服力的哮喘吸入器。
  • DOI:
    10.1016/j.jbi.2017.02.003
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Grossman,Brent;Conner,Steve;Mosnaim,Giselle;Albers,Joshua;Leigh,Jason;Jones,Steve;Kenyon,Robert
  • 通讯作者:
    Kenyon,Robert
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Giselle Sarah Mosnaim其他文献

Giselle Sarah Mosnaim的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Giselle Sarah Mosnaim', 18)}}的其他基金

Coping Peer Intervention for Adherence in Urban African American Adolescents with
应对城市非裔美国青少年依从性的同伴干预
  • 批准号:
    8099537
  • 财政年份:
    2010
  • 资助金额:
    $ 13.28万
  • 项目类别:
Coping Peer Intervention for Adherence in Urban African American Adolescents with
应对城市非裔美国青少年依从性的同伴干预
  • 批准号:
    7989800
  • 财政年份:
    2010
  • 资助金额:
    $ 13.28万
  • 项目类别:
Adolescents' Disease Empowerment and Persistency Technology for Asthma
青少年哮喘疾病赋权和持续技术
  • 批准号:
    7898828
  • 财政年份:
    2009
  • 资助金额:
    $ 13.28万
  • 项目类别:
Adolescents' Disease Empowerment and Persistency Technology for Asthma
青少年哮喘疾病赋权和持续技术
  • 批准号:
    8119550
  • 财政年份:
    2009
  • 资助金额:
    $ 13.28万
  • 项目类别:
Adolescents' Disease Empowerment and Persistency Technology for Asthma
青少年哮喘疾病赋权和持续技术
  • 批准号:
    8309988
  • 财政年份:
    2009
  • 资助金额:
    $ 13.28万
  • 项目类别:
Adolescents' Disease Empowerment and Persistency Technology for Asthma
青少年哮喘疾病赋权和持续技术
  • 批准号:
    7740550
  • 财政年份:
    2009
  • 资助金额:
    $ 13.28万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.28万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.28万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 13.28万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.28万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 13.28万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.28万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.28万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.28万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 13.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 13.28万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了